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ABSTRACT: ABHD2 is a serine hydrolase that belongs to
the subgroup of the α,β-hydrolase fold-containing proteins,
which is involved in virus propagation, immune response, and
fertilization. Chemical tools to selectively modulate the
activity of ABHD2 in an acute setting are highly desired to
investigate its biological role, but are currently lacking. Here,
we report a library-versus-library screening using activity-
based protein profiling (ABPP) to evaluate in parallel the
selectivity and activity of a focused lipase inhibitor library
against ABHD2 and a panel of closely related ABHD proteins.
This screen resulted in the rapid identification of novel
inhibitors for ABHD2. The selectivity of the inhibitor was further investigated in native mouse testis proteome by competitive
ABPP, revealing a highly restricted off-target profile. The progesterone-induced acrosome reaction was reduced in a dose-
dependent manner by the newly identified inhibitor, which provides further support for the key-role of ABHD2 in the P4-
stimulated acrosome reaction. On this basis, the ABHD2 inhibitor is an excellent starting point for further optimization of
ABHD2 inhibitors that can modulate sperm fertility and may lead to novel contraceptives.
The protein family containing the α,β-hydrolase fold is oneof the largest and most diverse protein families, covering
most, albeit not all, serine hydrolases. The α,β-hydrolase fold
family includes lipases, esterases, epoxidases, peroxide hydro-
lases, and dehalogenases.1,2 A subgroup of the the α,β-
hydrolase family consists of 22 members sharing the ABHD
(α/β hydrolase fold domain) nomenclature. They generally
have a GXSXG motif, and conserved structural features shared
by this subfamily predict common roles in lipid biosynthesis
and metabolism.3
Deregulated lipid metabolism is the underlying cause of
many human disorders.4,5 In line with this, ABHD11 is deleted
in the Williams-Beuren syndrome,6 and mutations in ABHD12
have been shown to be causative in polyneuropathy, hearing
loss, ataxia, retinitis pigmentosa, and cataract (PHARC).7 The
α,β-hydrolase domain-containing protein 2 (ABHD2) is
essential in hepatitis B virus propagation8 and is associated
with chronic diseases that involve monocyte/macrophage
recruitment, such as emphysema and atherosclerosis.9−11
ABHD2 has been identified as a progesterone (P4)-dependent
2-arachidonoylglycerol (2-AG) hydrolase.12 2-AG is an
endogenous inhibitor of the CatSper channel in spermatozoa.
Upon progesterone stimulation, ABHD2 hydrolyzes 2-AG,
leading to a CatSper opening that triggers sperm hyper-
activation and makes spermatozoa fertile. Despite the
potentially important role of ABHD2 during various (patho)-
physiological processes, such as virus propagation, athero-
sclerosis, and fertilization, selective small molecule inhibitors
are currently not available to study the biological role of this
enzyme in an acute setting.
Activity-based protein profiling is a valuable technology to
rapidly identify novel inhibitors. It makes use of activity-based
probes (ABPs) that assess the functional state of enzymes in
complex proteomes.13−15 We have previously shown that the
β-lactone-based ABPs MB064 and MB108 target a broad range
of serine hydrolases and can be used for inhibitor discovery
Received: August 6, 2019
Accepted: September 17, 2019
Published: September 17, 2019
Articles
pubs.acs.org/acschemicalbiologyCite This: ACS Chem. Biol. 2019, 14, 2295−2304
© 2019 American Chemical Society 2295 DOI: 10.1021/acschembio.9b00640
ACS Chem. Biol. 2019, 14, 2295−2304
This is an open access article published under a Creative Commons Non-Commercial No
Derivative Works (CC-BY-NC-ND) Attribution License, which permits copying and























































































and profiling.16−18 Here, we describe the target scope of
MB064 and MB108 and map the activity of ABHD2 in eight
different mouse tissues. Next, we tested 200+ lipase-directed
inhibitors on ABHD2 and related ABHD-proteins in a library-
versus-library screen. Such a screen facilitated the rapid
identification of selective inhibitors for ABHD2, which reduced
the acrosome reaction in mouse spermatozoa.
■ RESULTS
Identification of α,β-Hydrolase Fold-Containing Pro-
teins Targeted by MB064 and MB108. Previously, a large
variety in expression for α,β-hydrolase fold family members
across different tissue types has been observed by in situ
hybridization and in global proteomics studies.3,13,19,20 There-
fore, it was investigated whether this tissue-specific expression
was mirrored by enzyme activity as measured by MB064. The
labeling profile of MB064 in the mouse cytosol and membrane
fractions of the brain, heart, kidney, liver, lung, pancreas,
spleen, and testis revealed a highly diverse labeling pattern
across different tissue types (Figure 1B). To determine the
identity of the proteins, a tissue-wide chemoproteomic screen
was performed by using MB108, a biotinylated analog of
Figure 1. Detection of α,β-hydrolase fold enzyme activity in the mouse brain proteome, by using β-lactone-based ABPs MB064 and MB108. (A)
Chemoproteomic screen of α,β-hydrolase fold enzyme activity in the mouse proteome, by using β-lactone-based activity-based probe MB108 (10
μM). Mean of the average spectral counts over three replicate experiments. Heatmap: proteins are ordered by hierarchical clustering. Intensities in
blue represent the relative activity per protein in each tissue. Intensities in orange are the spectral counts in the tissue where the protein shows
highest activity. (B) In-gel fluorescence readout of mouse tissues labeled by ABP MB064 (2 μM) in the membrane and cytosolic mouse proteomes.
(C) Phylogenetic tree of α,β-hydrolase fold proteins generated by multiple sequence alignment (Muscle) and ClustalW2 omega phylogeny.
Proteins highlighted in red are targeted by MB108. All proteins are serine hydrolases except those in bold or highlighted in blue. Blue proteins lack
a catalytic triad. Bold proteins have a cysteine or asparagine as a catalytic residue. Gray dots indicate organophosphate-targeted proteins.
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MB064 (Figure 1A).16 As a reference for probe targets, a list of
α,β-hydrolase fold enzymes was retrieved from the ESTHER
database (http://bioweb.ensam.inra.fr/esther).21 A phyloge-
netic tree of 136 α,β-hydrolase fold containing enzymes was
generated using multiple sequence alignment (Muscle) and
ClustalW2 omega phylogeny (Figure 1C).22 The α,β-hydrolase
fold-containing proteins detected in this chemoproteomic
screen are highlighted in red. The screen revealed that 66 out
of the 136 known mouse α,β-hydrolase fold proteins, including
ABHD2, were detected by MB108 in one or more tissues. In
addition, a number of hydrolases and transferases that did not
contain the α,β-hydrolase fold motif, but had a catalytic
nucleophile that can attack the β-lactone, were also targeted
(SI Figure 1). Interestingly, ABHD2 activity was most
abundant in testis followed by kidney and liver.
It is well-known that α,β-hydrolase fold proteins react well
with organophosphates.23 Therefore, organophosphate-based
ABPs are widely applied tools to study α,β-hydrolase fold
protein enzymatic activity.24 For example, Bachovchin and
colleagues have previously targeted >80% of mammalian
metabolic serine hydrolases by using a single fluorophospho-
nate (FP)-based ABP.13 To study whether β-lactone-probe
targets are complementary to proteins that are known to
interact with organophospates, the FP-probe targets are
marked with a gray dot in Figure 1C. A large overlap between
the targets of organophosphates and MB108 was observed. Of
note, MB108 targeted DAGLα, FAM135, FAM135B, CES5A,
and ABHD14A, which were not detected in studies with
organophosphate-based probes.13,23 In conclusion, the β-
lactone-based ABPs, MB064, and MB108 are powerful
Figure 2. (A) Phylogenetic tree of the α,β-hydrolase fold family members sharing the ABHD nomenclature. The tree is generated by multiple
sequence alignment (Muscle) and ClustalW2 omega phylogeny. Proteins used for the inhibitor screen are highlighted in red. (B) Labeling of
ABHD proteins overexpressed in HEK293T or U2OS cells. Protein labeling of ABHD transfected cells was compared to mock transfected cells in
the membrane (M) and cytosolic (C) fractions. Proteins (1 mg mL−1) were labeled by ABP MB064 (2 μM). Overexpressed proteins are marked by
a red triangle. (C) Anti-FLAG Western blot for confirmation of protein expression and localization of the transfected ABHD. Cutout at the
molecular weight indicated by the red triangle is represented. Full gels and blot are given in SI Figures 2 and 3.
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broad-spectrum tools to study the ABHD2 activity and detect
many members of the α,β-hydrolase fold family (∼50%),
including several members that were not detected by
organophosphate-based probes.13,23
Gel-Based Screen to Identify Novel Inhibitors for
ABHD Family Members. To identify selective ABHD2
inhibitors, a competitive screen between ABHD proteins and a
targeted lipase inhibitor library with 207 members (Supporting
Table 2) was made. Chemoproteomic ABPP is highly sensitive
and allows one to study native enzymes with relatively low
abundance and activity in tissues or cells. However, chemo-
proteomics is expensive and time-consuming, and thus it is not
suitable for high-throughput screening of inhibitor libraries.
Therefore, a gel-based assay using MB064 was employed to
identify novel inhibitors for ABHD2 and its family members. It
is still sometimes challenging to correlate enzymes to specific
fluorescent bands on SDS-PAGE in native proteomes, and
native enzymes may show large variations in labeling
intensities, due to unequal tissue distribution. Thus, to avoid
these limitations we expressed recombinant proteins to
generate protein libraries for inhibitor screening.
The human enzymes sharing the ABHD nomenclature
corresponding to the enzymes that were detected in the
chemoproteomic mouse tissue screen (ABHDs 3, 4, 6, 11, 12,
and 16A) were recombinantly expressed in HEK293T (Figure
2A). The constructs were equipped with a FLAG-tag to
Figure 3. (A) Fluorescent labeling (MB064, 2 μM) of HEK293T/and or U2OS lysates that overexpress ABHD4, 6, 11, 16A and DAGL-α, and a
combination thereof to form protein library 1. (B) Fluorescent labeling (MB064, 2 μM) of HEK293T lysates that overexpress ABHD12, 3, 2 and a
combination thereof to form protein library 2. (C) Graphical representation of the number of hits per chemotype per enzyme. (D) Heatmap
overview of the inhibitor screen.
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monitor protein expression and gel migration. Instead, ABHD2
was expressed in U2OS cells because the efficiency of
expression of its construct in HEK293T cells was too low.
No expression or labeling of ABHD10, 14A, 14B, and 16B in
HEK293T nor U2OS could be achieved for as yet unclear
reasons (SI Figures 1, 2). Labeling with MB064 (2 μM) of
lysates from ABHD transfected cells compared to mock
transfected cells was used to monitor protein activity. To
establish a multiple protein assay, recombinantly expressed
proteins were pooled in protein libraries. ABHD3, 4, and 12
clustered around a molecular weight of ∼40 kDa. Therefore,
two protein libraries were required to resolve all expressed
ABHDs using 1D SDS-PAGE. Protein library 1 contained
ABHD2, 3, and 12, and protein library 2 consisted of ABHD4,
6, 11, and 16A (Figure 3A,B).
The lipase-focused inhibitor library contained 207 com-
pounds that can be divided in 3 major classes (α-ketoamides,
β-ketoamides, and 1,2,4-triazole ureas), and a set of unique
chemotypes (singletons). Screening of the compound library at
a concentration of 10 μM against the 2 protein libraries
generated ∼1500 protein−inhibitor interaction data points and
revealed that all proteins were hit by one or more compounds
(Figure 3C,D). Inhibitors were qualified as a hit when protein
labeling was reduced >70% compared to the vehicle-treated
control. A clear distinction between target profiles of different
inhibitor classes was detected (Figure 3C). The α-ketoamides
were inactive against all tested ABHD family members. The β-
ketoamides provided an excellent chemotype to inhibit
ABHD3: 21 hits were identified, 13 of which were considered
selective (<50% inhibition of the other ABHDs). Compounds
47 and 60 were the most potent ABHD3 inhibitors that
remained selective over the other measured ABHDs. Inhibitors
from the 1,2,4-triazole-urea class were more reactive. This class
effectively targeted ABHD6 and ABHD11 (>70% of the
compounds were classified as hits). No selective inhibitors
were found for ABHD4, 6, 11, 12, or 16A, yet the nonselective
compounds may still represent interesting starting points for
hit optimization programs. Compound 183 and 184 from the
singletons reduced the labeling of ABHD2 by >70% without
reducing the labeling of other ABHD’s by >50%. In a
concentration−response experiment, a modest pIC50 of 5.50
± 0.06 was determined for 183 (Figure 4A,B). The structurally
related compound 184, with a pyrrolidine moiety, had a 10-
fold lower activity (pIC50 of 4.60 ± 0.10).
Inhibitor Selectivity. To investigate the selectivity of
inhibitor 183 in more detail in a native mouse proteome,
competitive ABPP with broad-spectrum FP-based serine
hydrolase probes (FP-TAMRA and FP-biotin) and the ABPs
MB064 and MB108 was employed.17 The fluorophosphonate
was added to broaden the scope of the selectivity profile.13
Because of the important role in sperm fertility and the high
expression of ABHD2 in the testis, the selectivity of ABHD2
inhibitor 183 (20 μM, 30 min) was investigated in the mouse
testis proteome using MB064 and TAMRA-FP (Figure 5A,C).
Inhibitor 183 reduced labeling of one fluorescent band in the
cytosolic proteome, as determined by FP-TAMRA. The
competitive chemoproteomic assay confirmed ABHD2 inhib-
ition, with no other targets being detected (Figure 5B,D).
Together, these studies indicate that inhibitor 183 shows a
highly restrictive off-target profile and can be used to inhibit
ABHD2 in the testis proteome in an acute fashion.
Compound 183 Reduces Acrosome Reaction and
Inhibits ABHD2 Activity in Vitro. The acrosome reaction
(AR) is a crucial process that enables capacitated spermatozoa
to fertilize mammalian eggs.25,26 AR precedes sperm
penetration through the zona pellucida and fusion with the
oocyte membrane. This process is calcium-dependent, and it is
induced in mammals in capacitated spermatozoa through the
stimulation by several molecules, including the steroid
hormone progesterone (P4).
12,27 Intracellular calcium elevation
triggers the fusion between the sperm plasma membrane and
the outer acrosomal membrane. In order to monitor the
dynamic of such a key event, Peanut Agglutinin-Fluorescein
isothiocyanate (PNA-FITC) that selectively binds to the sugar
residues present in the acrosome of spermatozoa has been
used. Therefore, PNA-FITC staining allowed one to
distinguish sperm with intact acrosome (Figure 6A) from AR
ones.28
In vitro capacitated spermatozoa exposed to P4 (3 μM)
significantly increased the incidence of AR (from approx-
imately 20% to 35%). ABHD2 inhibitor 183 reduced P4-
induced AR in a concentration-dependent manner (Figure
6B). The broad spectrum serine hydrolase inhibitor MAFP
that was used as a positive control exerted similar inhibitory
action.12 Next, intracellular calcium measurements in mouse
sperm were performed. Treatment with 183 (2 μM) blocks the
calcium increase induced by P4, indicating a role of ABHD2 in
the regulation of intracellular calcium levels in mouse sperm
(Figure 6C). To further corroborate these functional data,
ABHD2 was overexpressed in U2OS cells, and its activity was
measured in vitro by a monoacylglycerol-lipase ABHD2 activity
assay. Of note, ABHD2 activity was found to be enhanced by
P4, and to be reduced by MAFP (used as a positive control)
12
and dose-dependently by 183 (Figure 7).
Figure 4. Structure−activity relationships of lead inhibitors for
ABHD. (A) Dose-dependent effect of 183 and 184 on ABHD2
labeling by MB064 (2 μM) on gel. (B) Dose−response curve of
inhibitor 183 (pIC50 = 5.50 ± 0.06) and 184 (pIC50 = 4.60 ± 0.10).
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■ DISCUSSION
The target profile of the β-lactone containing ABPs (MB108
and MB064) across the mouse proteome (spleen, pancreas,
liver, testis, brain, kidney, heart, and lung) was mapped. The
ABPs interacted with ABHD2 and almost 50% of the α,β-
hydrolase fold superfamily, including FAM135A, FAM135B,
ABHD14B, and CES5A, which were not previously detected
by organophosphates.13,23 The broad interaction landscape of
the β-lactone-containing ABPs enabled the parallel screening
of a targeted serine hydrolase inhibitor library for ABHD2 and
multiple other ABHD enzymes. This led to the rapid
identification of compound 183 as a novel inhibitor for
ABHD2.
Recently, ABHD2 was shown to be highly expressed in
spermatozoa, to bind P4, and to act as a P4-dependent 2-AG
hydrolase.12 It finely tunes endogenous inhibition of the sperm
calcium channel (Catsper) by 2-AG. Indeed, depletion of 2-AG
by the hydrolytic activity of ABHD2 enables calcium influx via
Catsper, leading to sperm activation in humans. A previous
report indicated that murine Catsper is insensitive to P4, and
may therefore lack regulation by ABHD2.29 Differential
localization of ABHD2 in murine (restricted to the acrosomal
region) compared to human (acrosomal region and flagellum)
spermatozoa may explain the lack of murine Catsper regulation
by P4, while still exhibiting a P4-induced acrosome reaction.
12
The percentage of murine P4-stimulated acrosome reacted
spermatozoa was reduced by the newly identified ABHD2
inhibitor 183. In addition, we have shown that the P4 induced
calcium increase in mouse spermatozoa is blocked by the
inhibition of ABHD2 using 183. A different calcium channel
from Catsper could be involved in a ABHD2 regulated calcium
flux in mouse sperm. Further research is required to identify
the molecular components that constitute the pathway
downstream of ABHD2 that regulates the acrosome reaction
in mouse spermatozoa. Of note, the previously used inhibitor
MAFP12 is known to target numerous endocannabinoid
hydrolases, including fatty acid amide hydrolase (FAAH),
monoacylglycerol lipase (MAGL), and ABHD6,30 whereas the
ABHD2 inhibitor 183 displayed a highly restricted off-target
profile in the mouse testis. Therefore, here we have provided
further support to the key-role of ABHD2 in the P4-stimulated
acrosome reaction. On this basis, 183 seems to represent an
excellent starting point for further optimization of ABHD2
inhibitors that can modulate sperm fertility by preventing a
sperm−egg recognition mechanism and may lead to a novel
formulation of contraceptives. On a final note, it should be
noted that the cross-talk between P4 and the ABHD2-
dependent endocannabinoid metabolism appears to be of
Figure 5. Chemoproteomic assay for ABHD2 selectivity in mouse testis. (A) Gel-based competitive ABPP with inhibitor 183 (2 and 20 μM) and
MAFP (2 μM) against TAMRA-FP (2 μM) in the mouse testis cytosolic and membrane fractions. (* indicates a band reduced in 183 treated vs
control.) (B) Competitive chemoproteomic selectivity assay of inhibitor 183 (20 μM) in the testis proteome using ABP FP-biotin (10 μM). (C)
Gel-based competitive ABPP with inhibitor 183 (2 and 20 μM) and MAFP (2 μM) against MB064 (2 μM) in the mouse testis cytosolic and
membrane fractions. (D) Competitive chemoproteomic selectivity assay of inhibitor 183 (20 μM) in the mouse testis proteome using ABP MB108
(10 μM).
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broad interest, and clearly extends previous data on the ability
of P4 and strictly related steroid hormones to control other
elements of endocannabinoid signaling, like the anandamide-
hydrolase FAAH,31,32 and the endocannabinoid-binding CB1
receptors.33 Overall, this cross-talk brings about an unprece-
dented type of regulation, whereby 2-AG signaling is
continuously “on” (to block Catsper), unless P4 terminates it
by stimulating 2-AG hydrolysis by ABHD2.12 Therefore, the
widely accepted dogma of the “on demand” synthesis of 2-AG,
that suggests that this compound acts only upon stimulus-
dependent release from phospholipid precursors, might not
hold true in all tissues, extending previous observations on
anandamide (AEA).34
■ EXPERIMENTAL METHODS
Cell Culture. Cell culture was performed as described
previously.17 In brief, HEK293T or U2OS cells were grown in
DMEM with stable glutamine and phenol red (PAA), 10% newborn
calf serum, penicillin, and streptomycin. Cell passage was performed
every 2−3 days by resuspension in medium and seeding to
appropriate confluence.
Transfection and Cell Lysis. 24 h prior to transfection, 107 cells
were seeded in a 15 cm Petri dish. A 3:1 mixture of polyethylenimine
(60 μg) and plasmid DNA (20 μg) in 2 mL serum free medium was
added. The medium was refreshed after 24 h, and after 72 h,
HEK293T (48 h for U2OS) cells were harvested in 20 mL medium.
Cells were isolated by centrifugation for 10 min at 1000 rpm and
subsequent aspiration of the medium. The cell pellet was flash-frozen
in liquid nitrogen and stored at −80 °C until use.
Cell pellets were slowly thawed on ice and suspended in lysis buffer
(20 mM HEPES pH 7.2, 2 mM DTT, 0.25 M sucrose, 1 mM MgCl2,
25 U/mL Benzonase). Three pulses with a polytrone (3 × 7 s) were
used to homogenize the suspension. After homogenization, the
Figure 6. (A) Representative image of one acrosome intact and one AR spermatozoa with the acrosomal enzymatic content and the nuclei stained
with the PNA-FITC (green fluorescence) and DAPI (blue fluorescence), respectively. (B) Incidence of AR recorded on in vitro capacitated
spermatozoa exposed to progesterone (P4:3 μM) in the absence (Ctrl) or presence of increasing concentrations of MAFP and 183 (from 0.2 nM
to 2 μM). The induction of AR promoted by P4 was prevented in spermatozoa treated with 2 μM of MAFP or 183. In order to exclude any toxic
effect, in vitro capacitated spermatozoa were also incubated with 2 μM of both the inhibitors (MAFP and 183 groups) without any treatment of P4.
Data are expressed as mean with SD of n = 3 independent experiments. One-way ANOVA followed by post hoc Tukey’s multiple comparisons test.
(C) Intracellular calcium analysis. Stimulation with P4 increases intracellular calcium levels in mouse spermatozoa as measured using Fluo-3 AM.
183 (2 μM) blocks the rise in intracellular calcium levels 5, 10, and 15 min after P4 stimulation. The data are expressed as florescence arbitrary
units (Arb. Units) and are the mean ± standard deviation of three independent samples (full time course and positive control with ionomycin is
given in SI Figure S9). *P < 0.05, **P < 0.01, ****P < 0.0001
Figure 7. (A) Representative image of U2OS cells transfected with
ABHD2-GFP (green) plasmid. (B) Effect of progesterone (P4) on
ABHD2 in vitro activity, when added directly to the culture medium
alone or in the presence of MAFP and 183. Data are expressed as
mean with SD of n = 3 independent experiments. *p < 0.05 and ***p
< 0.001.
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suspension was allowed to incubate for 10 min on ice. Ultra-
centrifugation (100,000 × g, 45 min, 4 °C, Beckman Coulter, Type
Ti70 rotor) was used to separate the cytosolic and membrane
fractions. The pellet (membrane fraction) was suspended in storage
buffer (20 mM HEPES pH 7.2, 2 mM DTT). The total protein
concentration was determined with Quick Start Bradford assay
(Biorad) or Qubit protein assay (Invitrogen). The lysates were flash-
frozen in liquid nitrogen and stored at −80 °C until use.
Preparation of Mouse Tissue Proteome. Mouse tissue was
isolated according to guidelines approved by the ethical committee of
Leiden University (DEC#13191). Mouse tissues were dounce
homogenized in pH 7.2 lysis buffer A (20 mM HEPES pH 7.2, 2
mM DTT, 1 mM MgCl2, 25 U/mL Benzonase) and incubated for 5
min on ice. The suspension was centrifuged (2500 × g, 3 min, 4 °C)
to remove debris. The supernatant was collected and subjected to
ultracentrifugation (100,000 × g, 45 min, 4 °C, Beckman Coulter,
Type Ti70 rotor). This yielded the membrane fraction as a pellet and
the cytosolic fraction in the supernatant. The membrane fraction was
suspended in a storage buffer (20 mM HEPES pH 7.2, 2 mM DTT).
The total protein concentration was determined with a Quick Start
Bradford assay (Biorad) or Qubit protein assay (Invitrogen).
Membranes and supernatant were flash-frozen in liquid nitrogen
and stored in aliquots at −80 °C until use.
Gel-Based Tissue Screen (MB064). The membrane or lysate
fraction of mouse brain, heart, kidney, liver, lung, pancreas, spleen, or
testis was diluted to 1 mg mL−1. Proteome (1 mg mL−1, 20 μL) was
incubated at 37 °C for 15 min with MB064 (1 μM, final
concentration). After 15 min the reactions were quenched with 10
μL standard 3 × SDS-PAGE sample buffer. The samples were directly
loaded and resolved on SDS PAGE gel (10% acrylamide). The gels
were scanned using a ChemiDoc MP system (Cy3 settings, 605/50
filter) and analyzed using Image lab 4.1.
Chemoproteomic Tissue Screen. The membrane or lysate
fraction of mouse brain, heart, kidney, liver, lung, pancreas, spleen, or
testis was diluted to 2 mg mL−1. The proteomes (490 μL) were
incubated with 10 μL of 500 μM ABP MB108 (final concentration 10
μM) for 1 h at rt. The labeling reaction was quenched, and excess
probe was removed by chloroform methanol precipitation.
Precipitated proteome was suspended in 500 μL 6 M urea/25 mM
ammonium bicarbonate and allowed to incubate for 15 min. 5 μL of 1
M DTT was added, and the mixture was heated to 65 °C for 15 min.
The sample was allowed to cool to rt before 40 μL (0.5 M)
iodoacetamide was added, and the sample was alkylated for 30 min in
the dark. 140 μL 10% (wt/vol) SDS was added and the proteome was
heated for 5 min at 65 °C. The sample was diluted with 6 mL PBS.
100 μL of 50% slurry of Avidin−Agarose from egg white (Sigma-
Aldrich) was washed with PBS and added to the proteome sample.
The beads were incubated with the proteome for 3 h.
Beads were isolated by centrifugation and washed with 0.5% (wt/
vol) SDS and PBS (3×). The proteins were digested overnight with
sequencing grade trypsin (Promega) in 100 μL Pd buffer (100 mM
Tris Ph 7.0, 100 mM NaCl, 1 mM CaCl2, 2% ACN, and 500 ng
trypsin) at 37 °C with vigorous shaking. The pH was adjusted with
formic acid to pH 3 and the beads were removed. The samples were
further purified and measured as described previously.16
Enzyme Mixes for Inhibitor Screen. Protein library 1 is made in
standard assay buffer (20 mM HEPES pH 7.2, 2 mM DTT) and
contains the following transiently transfected proteins (concentrations
are final concentrations): 4 mg mL−1 cytosolic fraction of ABHD12
transfected HEK293T cell lysate, 0.3 mg mL−1 membrane fraction
ABHD3 transfected HEK293T cell lysate, and 1 mg mL−1 membrane
fraction of ABHD2 transfected U2OS cell lysate.
Protein library 2 is made in standard assay buffer (20 mM HEPES
pH 7.2, 2 mM DTT) and contains the following transiently
transfected proteins (concentrations are final concentrations): 1 mg
mL−1 cytosolic fraction of ABHD4 transfected HEK293T cell lysate,
0.25 mg mL−1 membrane fraction ABHD6 and 11 transfected
HEK293T cell lysate, 0.2 mg mL−1 membrane fraction ABHD16A
transfected HEK293T cell lysate, and finally 0.5 mg mL−1 membrane
fraction DAGL-α transfected HEK293T cell lysate.
Inhibitor Screen. Enzyme mix 1 or 2 (19.5 μL) was incubated
with DMSO (0.5 μL) or inhibitor (0.5 μL, 400 μM; 10 μM final
concentration) for 30 min at 37 °C. Next, MB064 (0.5 μL, 80 μM; 2
μM final concentration) was incubated for 15 min at 37 °C. The
reactions were quenched with 10 μL standard 3×SDS PAGE sample
buffer. The samples were directly loaded and resolved on SDS PAGE
gel (10% acrylamide). The gels were scanned using a ChemiDoc MP
system (Cy3 settings, 605/50 filter), and the percentage inhibition
was determined by comparison with DMSO (100%) using Image Lab
4.1. Control for protein loading was performed by Coomassie staining
and adjustment for total lane intensity.
Gel-Based Dose−Response Analysis. Dose response analysis
was performed as described previously.16 In brief, transfected
proteome (19.5 μL) was incubated with DMSO (0.5 μL) or inhibitor
(0.5 μL) at the indicated final concentrations for 30 min at 37 °C.
Next, MB064 (0.5 μL, 80 μM; 2 μM final concentration) was
incubated for 15 min at 37 °C. The reactions were quenched with 10
μL standard 3×SDS PAGE sample buffer. The samples were directly
loaded and resolved on SDS PAGE gel (10% acrylamide). The gels
were scanned using a ChemiDoc MP system (Cy3 settings, 605/50
filter); the percentage of activity remaining was determined by
measuring the integrated optical intensity of the fluorescent protein
bands using Image Lab 4.1. The relative intensity was compared to
the vehicle treated proteins, which were set to 100%. Correction for
protein loading was performed by Coomassie staining. IC50 values
were determined by plotting log(inhibitor) vs normalized response
(variable slope); dose−response curve was generated using Prism
software (GraphPad).
Selectivity in Native Mouse Proteome. Mouse testis or brain
cytosolic or membrane fractions were diluted to a total protein
concentration of 2 mg mL−1. Proteome (19.5 μL) was incubated with
DMSO (0.5 μL) or inhibitor (0.5 μL, 20 μM final concentration) for
30 min at 37 °C. Next, MB064 or TAMRA-FP (0.5 μL, 80 μM; 2 μM
final concentration) was incubated for 15 min at 37 °C. The reactions
were quenched with 10 μL standard 3×SDS PAGE sample buffer and
analyzed as described above.
Chemoproteomic Selectivity Assay in Native Mouse
Proteome. Mouse testis or brain cytosolic or membrane fraction
was diluted to a total protein concentration of 2 mg mL−1. 5 μL of 1
mM inhibitor (20 μM final concentration) or DMSO was added to
240 μL proteome and allowed to incubate for 30 min at 37 °C. FP-
Biotin or MB108 (5 μL, 500 μM) was added and incubated for 30
min at 37 °C. The samples were further processed and analyzed as
described previously.16
Monoacylglycerol-Lipase ABHD2 Activity. Monoacylglycerol-
lipase ABHD2 activity was assayed in transfected U2OS cell
membrane (100,000g fraction; 100 μg for each point). Membranes
were preincubated with serine protease/hydrolase inhibitor, MAFP
(2.0 μM) (Cayman Chemicals, Ann Arbor, MI, U.S.A.) or 183 (5, 10,
20 μM), for 15 min at 37 °C. 2-Oleoyl-[3H]glycerol (10 μM, 10,000
cpm for each points (ARC, St. Louis, MO, U.S.A.)) was added and
incubated for 30 min at 37 °C. The reaction was terminated by
addition of a 2:1 (v/v) mixture of chloroform/methanol and
centrifuged at 1600 rpm for 5 min, to induce phase separation.
[3H]Glycerol release in the aqueous phase was measured by
scintillation counting.
Acrosome Reaction. In each experimental group, two C57BL/
6NBD male mice were used. Spermatozoa were retrieved from
epididymis and vas deferens, and were incubated in TYH solution
under the reported experimental conditions.35 Each assay was
performed in triplicate.
Intracellular Calcium Levels. The spermatozoa were recovered
from 6 mice epididymis and incubated at 37 °C, 5% CO2; stained
with Fluo-3 AM; following a protocol by Bernabo ̀ et al.36 under
control (Ctrl) conditions or in the presence of the inhibitor (2 μM).
After 30 min, P4 was added at the final concentration of 5 μM. As a
positive control, both samples were added to Ionomycin 10 μM. The
fluorescence was assessed every 5 min with a fluorimeter (Fluoroskan
96 well Reader, PerkinElmer). The data are expressed as Florescence
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